Non-Invasive Nasal Discharge Fluid and Other Body Fluid Biomarkers in Alzheimer's Disease
The key to current Alzheimer's disease (AD) therapy is the early diagnosis for prompt intervention, since available treatments only slow the disease progression. Therefore, this lack of promising therapies has called for diagnostic screening tests to identify those likely to develop full-blown...
Saved in:
Main Authors: | Da Hae Jung (Author), Gowoon Son (Author), Oh-Hoon Kwon (Author), Keun-A Chang (Author), Cheil Moon (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease
by: Carolina A. Magalhães, et al.
Published: (2015) -
Cancer Biomarkers in Body Fluids
Published: (2023) -
Cancer Biomarkers in Body Fluids
Published: (2023) -
The meaning of blood and cerebrospinal fluid biomarkers in early diagnosis of Alzheimer's disease
by: Julita Szarpak, et al.
Published: (2020) -
Editorial: Perinatal assessment of biomarkers in invasive and non-invasive procedures of biological fluid collection
by: Iliana Bersani, et al.
Published: (2022)